The U.S. Centers for Disease Control and Prevention (CDC) is increasing its emergency response efforts as the Ebola outbreak in the Democratic Republic of the Congo and Uganda continues to worsen. According to an internal email obtained by Reuters, the agency has asked employees to volunteer for urgent deployment to assist with Ebola screening operations at U.S. entry points.
CDC Acting Director Jay Bhattacharya stated that the agency activated a Level 2 emergency response on May 18 following the spread of the Bundibugyo strain of the Ebola virus. The move reflects growing concern over the outbreak, which the World Health Organization (WHO) has labeled the third-largest Bundibugyo Ebola outbreak ever recorded.
As part of the enhanced response, the CDC is expanding recruitment beyond its traditional emergency response teams. Additional staff, including public health advisers, emergency specialists, and licensed medical providers, are being encouraged to participate with supervisor approval.
The screening operations are already active at several U.S. port health stations. Volunteers may be responsible for monitoring international travelers for Ebola symptoms, conducting temperature checks, and referring suspected cases for further medical evaluation.
The Bundibugyo strain of Ebola is a rare but highly dangerous virus spread through direct contact with infected bodily fluids. Ebola symptoms can include fever, fatigue, vomiting, bleeding, and severe weakness. Health experts warn that rapid identification and containment are critical to preventing wider transmission.
WHO Director-General Tedros Adhanom Ghebreyesus recently warned that the fast-moving outbreak is outpacing current response efforts in Africa. The latest reports indicate that at least 220 suspected deaths have been linked to the outbreak in Congo and Uganda.
The CDC’s expanded airport screening measures highlight growing international concern over the Ebola crisis and the need to strengthen global public health preparedness in 2026.


GSK Reportedly Nears $9 Billion Acquisition of Cancer Drug Developer Nuvalent
RFK Jr. Faces Scrutiny Over David Geier’s HHS Role and Vaccine Review Work
U.S. Officials Express Optimism Over New CDC Director Selection Amid Vaccine Policy Turmoil
Supreme Court Blocks 5th Circuit Ruling on Abortion Pill Access
UN Blacklists Israel and Russia Over Conflict-Related Sexual Violence Claims
New World Screwworm Found Near U.S. Border Raises Threat to Cattle Industry and Beef Prices
DOJ Sues Virginia Over Law Enforcement Mask Ban
Los Angeles World Cup Security Plans: No ICE Immigration Enforcement at FIFA 2026 Matches, Officials Say
Takeda Hit With $885M Verdict Over Amitiza Generic Drug Delay Scheme
ASIC Launches Formal Investigation Into KPMG Australia Partners Over Client Data Misuse Allegations
CDC Monitors U.S. Travelers After Hantavirus Outbreak on Luxury Cruise Ship
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
US Expands Iran Sanctions, Targets Major Crypto Exchanges and Individuals
US Launches New Trade Investigation Into Vietnam Over Intellectual Property Concerns
US Imposes Fresh Iran Oil Sanctions Despite Progress on Ceasefire Talks
Trump Administration Delays DeepSeek and CXMT Trade Blacklist Designations Amid U.S.-China Tensions 



